Amylin, amide, rat, is primarily used in research settings to study metabolic processes, particularly those related to diabetes and obesity. It is often employed in preclinical studies to understand its role in regulating glucose metabolism and appetite. Researchers use this peptide to investigate its effects on insulin secretion, gastric emptying, and satiety, which are crucial in managing metabolic disorders. Additionally, it serves as a tool to explore potential therapeutic applications for conditions like type 2 diabetes, where amylin analogs are being developed to improve glycemic control. Its use in animal models helps in understanding the physiological and pathological mechanisms of amylin in the body.